Sensitization of IL-2 signaling through TLR-7 enhances B lymphoma cell immunogenicity

The Journal of Immunology : Official Journal of the American Association of Immunologists
J TomicDavid E Spaner

Abstract

The innate ability of B lymphoma cells to escape control by tumor-reactive T cells must be overcome to develop effective immunotherapies for these diseases. Because signals from both the innate and adaptive immune systems direct the acquisition of strong immunogenicity by professional APCs, the effects of IL-2 and the TLR-7 agonist, S28690, on the immunogenic properties of chronic lymphocytic leukemia (CLL) B cells were studied. IL-2 with S28690 caused CLL cells to proliferate and increased their expression of B7-family members, production of TNF-alpha and IL-10, and levels of tyrosine-phosphorylated STAT-1 and STAT-3 proteins. S28690 increased CD25 expression on CLL cells and sensitized them to IL-2 signaling. However, IL-2 did not change TLR-7 expression or signaling in CLL cells. The ability to stimulate T cell proliferation required additional activation of protein kinase C, which inhibited tumor cell proliferation, "switched off" IL-10 production, and caused essentially all CLL cells (regardless of clinical stage) to acquire a CD83(high)CD80(high)CD86(high)CD54(high) surface phenotype marked by the activation of STAT-1 without STAT-3. These findings suggest that TLR-7 "licenses" human B cells to respond to cytokines of the...Continue Reading

References

Aug 15, 1995·Proceedings of the National Academy of Sciences of the United States of America·D A FrankM E Greenberg
Jan 1, 1993·Annual Review of Immunology·R N Germain, D H Margulies
Sep 16, 1998·Proceedings of the National Academy of Sciences of the United States of America·T K SenguptaL B Ivashkiv
Apr 16, 2002·Science·Polly Matzinger
Jun 20, 2002·Trends in Immunology·Matthias LechmannAlexander Steinkasserer
Jun 20, 2002·The Journal of Biological Chemistry·Katsutoshi Ozaki, Warren J Leonard
Dec 26, 2002·Annual Review of Immunology·Susanne J SzaboLaurie H Glimcher
Sep 23, 2003·Immunity·Fengdong ChengEduardo M Sotomayor
Feb 7, 2004·The Journal of Immunology : Official Journal of the American Association of Immunologists·Sharon H JacksonCharles E Egwuagu
Feb 14, 2004·Blood·Freda K Stevenson, Federico Caligaris-Cappio
May 4, 2004·Nature Reviews. Immunology·Lieping Chen
May 12, 2004·Current Opinion in Immunology·Beichu GuoDavid J Rawlings
Jul 2, 2004·Nature Reviews. Immunology·Shizuo Akira, Kiyoshi Takeda
Feb 8, 2005·The Journal of Biological Chemistry·Annett SchoenemeyerDouglas T Golenbock
Feb 25, 2005·The Journal of Immunology : Official Journal of the American Association of Immunologists·Bali Pulendran
Mar 18, 2005·Annual Review of Immunology·Tania H Watts
Mar 18, 2005·Annual Review of Immunology·Rebecca J GreenwaldArlene H Sharpe
Mar 22, 2005·The Journal of Immunology : Official Journal of the American Association of Immunologists·Isabelle Béatrice Bekeredjian-DingGunther Hartmann
May 27, 2005·Cancer Immunology, Immunotherapy : CII·David E SpanerAndrea Deabreu

❮ Previous
Next ❯

Citations

Aug 15, 2008·The Oncologist·Evelien L J M SmitsViggo F I Van Tendeloo
Aug 18, 2009·International Journal of Cancer. Journal International Du Cancer·Daniela RozkováRadek Spísek
Jan 15, 2014·Leukemia·M MasoodiD E Spaner
Sep 10, 2009·Clinical and Experimental Immunology·S P ShahaD E Spaner
Aug 21, 2008·The Journal of Immunology : Official Journal of the American Association of Immunologists·Gianni GerliniNicola Pimpinelli
Jan 20, 2011·Clinical Reviews in Allergy & Immunology·Emanual MaverakisMiki Shirakawa Garcia
Aug 8, 2015·Blood·Rosa Lapalombella
Oct 20, 2006·Cancer Immunology, Immunotherapy : CII·Amal MansourElizabeth Raveche
Aug 29, 2007·Blood·Caitlin M HammondDavid E Spaner
Nov 20, 2012·Leukemia·D E SpanerR Gorzcynski
Aug 28, 2019·Proceedings of the National Academy of Sciences of the United States of America·Wenqian ZhangFubin Li
Aug 13, 2013·PloS One·Amit K MittalShantaram S Joshi
Jan 30, 2015·Glia·Hee Jung YoonEun Jung Park
Oct 18, 2020·The Journal of Immunology : Official Journal of the American Association of Immunologists·Meihui XiaDavid E Spaner
Mar 24, 2020·European Journal of Medicinal Chemistry·Cindy PatinoteCarine Deleuze-Masquéfa
Mar 12, 2018·Leukemia Research·Fang ZhuReginald M Gorczynski

❮ Previous
Next ❯

Related Concepts

Related Feeds

B-Cell Lymphoma

B-cell lymphomas include lymphomas that affect B cells. This subtype of cancer accounts for over 80% of non-Hodgkin lymphomas in the US. Here is the latest research.

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Antivirals

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

B-Cell Leukemia (Keystone)

B-cell leukemia includes various types of lymphoid leukemia that affect B cells. Here is the latest research on B-cell leukemia.